Baruch Harris

Baruch Harris

Company: Pretzel Therapeutics

Job title: COO

Seminars:

Modulating Novel Mitochondrial Targets to Treat Mitochondrial Disease, Diseases of Aging & Metabolism 3:25 pm

Unveiling small molecule activators of the mitochondrial DNA polymerase, POLG, to treat mitochondrial DNA depletion syndromes and beyond Exploring inhibitors of the mitochondrial RNA polymerase, POLRMT, to treat obesity and metabolic disorders Leveraging a unique mitochondrial biology discovery platform to develop a pipeline of novel therapeuticsRead more

day: CONFERENCE DAY ONE

Panel Discussion: Translating Modality Into Value for Patients to Establish Clearly Defined Clinical Objectives 1:50 pm

Building on the industry’s failures to re-evaluate how to select and measure the right clinical outcome Steering the direction of research to acquire robust data that can illustrate clinical translatability and expedite discovery towards Phase I of clinical trials Positioning patients at the heart of the modality to demonstrate its viability, thereby eliminating the need…Read more

day: CONFERENCE DAY ONE

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.